Horsham: Johnson & Johnson has announced the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug ...

Buckingham Palace said Saturday that King Charles III “will be greatly encouraged and deeply touched” by the reaction to his ...

Expanded indication for AKEEGA® (niraparib and abiraterone acetate dual-action tablet) plus prednisone marks the first FDA-approved precision medicine combination treatment for patients with BRCA2-mut ...

The British monarch gave his first extensive public comments about his cancer journey since being diagnosed in February 2024.

This is the first time scientists have shown that a common type of drug resistance in prostate cancer can be reversed, not ...

November's wave of FDA oncology approvals signals the industry's shift toward platform-based precision therapies over broad-spectrum approaches([1]) . The global anticancer drug market now values ...

Winter arrives with shorter days, colder mornings, and a natural drop in energy. Many men start to feel small physical changes during this season, such as slower digestion, disrupted bowel habits, or ...

Francis Medical is heating up with a 510 (k) clearance from the FDA for its water vapor ablation therapy aimed at cancers of ...

BioNTech stock is a "Strong Buy", driven by positive phase 3 data for gotistobart in 2nd-line squamous NSCLC patients. Read ...

Francis Medical has received FDA clearance for its Vanquish water vapor ablation system for the management of prostate cancer ...

In a recent interview with CURE, Dr. Kai Tsao broke down current treatment advancements for patients with prostate cancer.